Return to Main Site 617-919-3019
401 Park Drive, 7th Floor East, Boston, MA 02215

TIDO Technology Search

Invention Type

Information Technology/Software
Medical Device
Research Tool

Research Area

Allergy/Respiratory/Pulmonary Disease
Degenerative Disease
Genetic Disease
Health Care Management
Infectious Disease
Internal Medicine
Metabolic Disease
Personalized Medicine
Psychiatric Disease
Regenerative Medicine
Stem Cell
Surgery/Wound Healing
CMCC 1894

Defining physiological functions of syndecan-1 in health and disease using the syndecan-1 null mice

Inventors: Merton Bernfield, Pyong Park

Invention Types: Research Tool

Research Areas: Cardiovascular/Cardiology, Inflammation, Infectious Disease

Keywords: Animal Model (mouse)

For More Information Contact:  Khunkhun, Rajinder


Invention Description:

ell surface heparan sulfate proteoglycans (HSPG) bind to a wide variety of bioactive molecules and regulate a wide variety of biological activities, including developmental processes, angiogenesis, blood coagulation, tumour metastasis, infection, and inflammation. Syndecan-1 is the major epithelial cell membrane HSPG in mammals. Dr. Pyong Park, PhD, from the Department of Respiratory Diseases, has developed a knock-out mouse by homologous recombination (mutation of exon 1 in a c57BL6 background) to study the physiological functions of syndecan-1 in health and in disease. Despite the variety of functional interactions that have been reported for syndecan-1 in cultured cells, Sdc1–/– mice are ostensibly normal and fertile. Dr. Park has shown that newborn mice deficient in syndecan-1 resist P. aeruginosa lung infection but become susceptible when given purified syndecan-1 ectodomains or heparin, but not when given ectodomain core protein, indicating that the ectodomain's heparan sulphate chains are the effectors. In wild-type newborn mice, inhibition of syndecan-1 shedding or inactivation of the shed ectodomain's heparan sulphate chains prevents lung infection. He also found that a pathogenetic mechanism in which a host response to tissue injury, syndecan-1 shedding, is exploited to enhance microbial virulence apparently by modulating host defenses. Additional work with the syndecan-1 knockout mice in tumorigenesis provided both genetic and biochemical evidence that syndecan-1 can modulate Wnt signalling, and is critical for Wnt-1–induced tumorigenesis of the mouse mammary gland. Further, recent studies indicate that syndecan-1 assures the correct functioning of inflammation by attenuating pro-inflammatory factors and facilitating the resolution of inflammation in a heparan sulfate-dependent manner.


The syndecan-1 knock-out mouse is thought to be a valuable research tool in defining:

• the underlying mechanisms of both physiological and pathological processes

• the precise functions of heparan sulfate proteoglycans and syndecan-1 in these mechanisms

These findings further suggest that syndecan-1 knock out mice can be used as a screening tool for drug development in:

• infection

• inflammation

• toxicosis

• cancer

• sepsis

• lipid metabolism

• wound repair

• epithelial barrier function

• cellular responses to growth factors, cytokines, chemokines, stress and proteinases|

Competitive Advantages:

The syndecan-1 null mice is not commercially available and other syndecan-1 null mice have not been generated. The syndecan-1 null mice used currently around the world is derived from the line developed at Children's Hospital Boston.

Business Opportunity:

• Non-exclusive license for research use

• Non-exclusive license for research tool distribution

• Collaboration or sponsored research

Key Publications: Park PW et al. Nature. 2001 May 3;411(6833):98; Alexander CM et al. Nature Genetics, 2000 July, Vol 25, p. 329.

Hayashida, K, Chen, Y, Bartlett, AH, and Park, PW, Syndecan-1 is an In Vivo Suppressor of Gram-positive Toxic Shock, J. Biol. Chem., 2008; 283: 19895-19903.

Hayashida, A, Bartlett, AH, Foster, TJ, and Park, PW, Staphylococcus aureus Beta-toxin Induces Acute Lung Injury through Syndecan-1, Am. J. Pathol., 2009; 174: 509-518.

Hayashida, K, Parks, WC, and Park, PW, Syndecan-1 Shedding Facilitates the Resolution of Neutrophilic Inflammation by Removing Sequestered CXC Chemokines, Blood, 2009; 114: 3033-3043.

IPStatus: No Protection